Chest
Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesExecutive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Section snippets
Summary of Recommendations
Note on Shaded Text: Throughout this guideline, shading is used within the summary of recommendations sections to indicate recommendations that are newly added or have been changed since the publication of Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Recommendations that remain unchanged are not shaded.
Evidence-Based Management of Anticoagulant Therapy
For further details, see Holbrook et al.1
Prevention of VTE in Nonsurgical Patients
For further details, see Kahn et al.2
Prevention of VTE in Nonorthopedic Surgical Patients
For further details, see Gould et al.3
Prevention of VTE in Orthopedic Surgery Patients
For further details, see Falck-Ytter et al.4
Perioperative Management of Antithrombotic Therapy
For further details, see Douketis et al.5
Diagnosis of DVT
For further details, see Bates et al.6
Antithrombotic Therapy for VTE Disease
For further details, see Kearon et al.7
Treatment and Prevention of Heparin-Induced Thrombocytopenia
For further details, see Linkins et al.8
Antithrombotic Therapy for Atrial Fibrillation
For further details, see You et al.9
Antithrombotic and Thrombolytic Therapy for Valvular Disease
For further details, see Whitlock et al.10
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
For further details, see Lansberg et al.11
The Primary and Secondary Prevention of Cardiovascular Disease
For further details, see Vandvik et al.12
Antithrombotic Therapy in Peripheral Artery Disease
For further details, see Alonso-Coello et al.13
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
For further details, see Bates et al.14
Antithrombotic Therapy in Neonates and Children
For further details, see Monagle et al.15
1.0. We suggest that where possible, pediatric hematologists with experience in thromboembolism manage pediatric patients with thromboembolism (Grade 2C). When this is not possible, we suggest a combination of a neonatologist/pediatrician and adult hematologist supported by consultation with an experienced pediatric hematologist (Grade 2C).
Acknowledgments
Financial/nonfinancial disclosures: In summary, the authors have reported to CHEST the following conflicts of interest: Dr Crowther has served on various advisory boards, has assisted in the preparation of educational materials, and has sat on data safety and monitoring boards. His institution has received research funds from the following companies: Leo Pharma A/S, Pfizer Inc, Boerhinger Ingelheim GmbH, Bayer Healthcare Pharmaceuticals, Octapharm AG, CSL Behring, and Artisan Pharma. Personal
References (15)
- et al.
Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines
Chest
(2012) - et al.
Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines
Chest
(2012) - et al.
Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines
Chest
(2012) - et al.
Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines
Chest
(2012) - et al.
Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines
Chest
(2012) - et al.
Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines
Chest
(2012) - et al.
Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines
Chest
(2012)
Cited by (0)
Funding/Support: The Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines received support from the National Heart, Lung, and Blood Institute [R13 HL104758] and Bayer Schering Pharma AG. Support in the form of educational grants were also provided by Bristol-Myers Squibb; Pfizer, Inc; Canyon Pharmaceuticals; and sanofi-aventis US.
Disclaimer: American College of Chest Physician guidelines are intended for general information only, are not medical advice, and do not replace professional medical care and physician advice, which always should be sought for any medical condition. The complete disclaimer for this guideline can be accessed at http://chestjournal.chestpubs.org/content/141/2_suppl/1S
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (http://www.chestpubs.org/site/misc/reprints.xhtml).
- 1
For complete panel list, see: http://chestjournal.chestpubs.org/content/141/2_suppl/2S